Physician profile
Megan E Leman
NPI 1235885906
$476.47
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.58 · 2023: $88.26 · 2024: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $146.36 | 2024 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $86.50 | 2024 | Nuedexta, Rexulti |
| Xeris Pharmaceuticals, INC. | $71.54 | 2023 | Gvoke Hypopen |
| Novo Nordisk INC | $59.58 | 2022 | |
| Sk Life Science, INC. | $31.05 | 2024 | Xcopri |
| Abbvie INC. | $29.66 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.99 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.72 | 2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.07 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Leman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.